[go: up one dir, main page]

FI971995L - Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä - Google Patents

Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä Download PDF

Info

Publication number
FI971995L
FI971995L FI971995A FI971995A FI971995L FI 971995 L FI971995 L FI 971995L FI 971995 A FI971995 A FI 971995A FI 971995 A FI971995 A FI 971995A FI 971995 L FI971995 L FI 971995L
Authority
FI
Finland
Prior art keywords
production method
macrocyclic lactone
lactone compounds
compounds
macrocyclic
Prior art date
Application number
FI971995A
Other languages
English (en)
Swedish (sv)
Other versions
FI971995A7 (fi
FI971995A0 (fi
Inventor
Hiroyuki Nishida
Yuji Yamauchi
Taisuke Inagaki
Yasuhiro Kojima
Nakao Kojima
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI971995A7 publication Critical patent/FI971995A7/fi
Publication of FI971995L publication Critical patent/FI971995L/fi
Publication of FI971995A0 publication Critical patent/FI971995A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
FI971995A 1994-11-10 1995-10-13 Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä FI971995A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9401896 1994-11-10
PCT/IB1995/000870 WO1996015131A1 (en) 1994-11-10 1995-10-13 Macrocyclic lactone compounds and their production process

Publications (3)

Publication Number Publication Date
FI971995A7 FI971995A7 (fi) 1997-05-09
FI971995L true FI971995L (fi) 1997-05-09
FI971995A0 FI971995A0 (fi) 1997-05-09

Family

ID=1341416

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971995A FI971995A0 (fi) 1994-11-10 1995-10-13 Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä

Country Status (12)

Country Link
US (2) US6001998A (fi)
EP (1) EP0854874B1 (fi)
JP (1) JP3061863B2 (fi)
AT (1) ATE239024T1 (fi)
CA (1) CA2204739C (fi)
DE (1) DE69530616T2 (fi)
DK (1) DK0854874T3 (fi)
ES (1) ES2194054T3 (fi)
FI (1) FI971995A0 (fi)
MX (1) MX9703484A (fi)
PT (1) PT854874E (fi)
WO (1) WO1996015131A1 (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854874B1 (en) * 1994-11-10 2003-05-02 Pfizer Inc. Macrocyclic lactone compounds and their production process
ATE411019T1 (de) * 2001-05-02 2008-10-15 Brni Neurosciences Inst Kohlensäureanhydrase-aktivatoren zur verbesserung der lern- und gedächtnisleistung
US6551591B1 (en) 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
US20050065205A1 (en) * 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
US20080004332A1 (en) * 2002-03-07 2008-01-03 Alkon Daniel L Methods for alzheimer's disease treatment and cognitive enhancement
CN1946656B (zh) * 2004-02-17 2011-08-24 托马斯·E·约翰逊 形成大环化合物的方法、组合物和设备
TW201206425A (en) * 2004-05-18 2012-02-16 Brni Neurosciences Inst Treatment of depressive disorders
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
CA2598805A1 (en) * 2005-02-24 2006-08-31 Biocern, Inc. Sperm cell separation methods and compositions
WO2006119211A2 (en) * 2005-05-02 2006-11-09 Genaera Corporation Methods and compositions for treating ocular disorders
EP1915145A1 (en) 2005-07-29 2008-04-30 Blanchette Rockefeller Neurosciences Institute Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
EP2762136A1 (en) 2006-07-28 2014-08-06 Blanchette Rockefeller Neurosciences, Institute Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memory
RU2475539C2 (ru) * 2006-08-30 2013-02-20 Байосерн, Инк. Способы разделения сперматозоидов и применяемые для этого композиции, содержащие аптамеры или последовательности нуклеиновых кислот
US10695327B2 (en) 2006-09-13 2020-06-30 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
JP6049160B2 (ja) 2006-09-13 2016-12-27 エリクシアー メディカル コーポレイション 大環状ラクトン化合物およびその使用方法
US8088789B2 (en) 2006-09-13 2012-01-03 Elixir Medical Corporation Macrocyclic lactone compounds and methods for their use
CA3006091A1 (en) 2007-02-09 2008-08-21 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
EP3332797A3 (en) 2007-02-09 2018-08-01 Blanchette Rockefeller Neurosciences Institute Therapeutic effects of bryostatins, bryologs and other related substances on head trauma-induced memory impairment and brain injury
CN102421441B (zh) * 2009-05-01 2015-04-01 糖模拟物有限公司 E-选择蛋白和cxcr4趋化因子受体的异双功能抑制剂
EP2473161B1 (en) * 2009-08-31 2017-05-17 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
CA2804789A1 (en) 2010-07-08 2012-01-12 Daniel L. Alkon Pkc activators and anticoagulant in regimen for treating stroke
US9597312B2 (en) 2010-08-19 2017-03-21 Cognitive Research Enterprises, Inc. Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activators
EP2776018B1 (en) 2011-11-13 2021-08-25 Cognitive Research Enterprises, Inc. Pkc activators and combinations thereof
WO2016183252A1 (en) 2015-05-11 2016-11-17 Alkon, Daniel, L. Treatment of neurodegenerative conditions using pkc activators after determining the presence of the apoe4 allele
CN107827803A (zh) * 2017-11-28 2018-03-23 绍兴厚普生物科技有限责任公司 一种从发酵液中提取l‑羟脯氨酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6903238A (fi) * 1968-03-04 1969-09-08
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
US5674732A (en) * 1992-04-27 1997-10-07 Pfizer Inc. Rapamycin producer
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
EP0854874B1 (en) * 1994-11-10 2003-05-02 Pfizer Inc. Macrocyclic lactone compounds and their production process

Also Published As

Publication number Publication date
CA2204739C (en) 2000-04-04
MX9703484A (es) 1997-08-30
FI971995A7 (fi) 1997-05-09
JPH11507907A (ja) 1999-07-13
ES2194054T3 (es) 2003-11-16
DE69530616T2 (de) 2004-04-01
PT854874E (pt) 2003-07-31
EP0854874B1 (en) 2003-05-02
ATE239024T1 (de) 2003-05-15
US6001998A (en) 1999-12-14
DE69530616D1 (de) 2003-06-05
JP3061863B2 (ja) 2000-07-10
WO1996015131A1 (en) 1996-05-23
DK0854874T3 (da) 2003-06-02
FI971995A0 (fi) 1997-05-09
EP0854874A1 (en) 1998-07-29
US6187568B1 (en) 2001-02-13

Similar Documents

Publication Publication Date Title
FI971995L (fi) Makrosykliset laktoniyhdisteet ja niiden tuotantomenetelmä
FI954246L (fi) Uusia A83543-yhdisteitä ja menetelmä niiden valmistamiseksi
FI973426L (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
FI960751A7 (fi) Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi
FI956270L (fi) Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI952408A7 (fi) Menetelmä absorboivan rakenteen valmistamiseksi ja menetelmällä valmis tetun rakenteen käsittävä absorboiva tuote
FI915432A7 (fi) Menetelmä rainan rullauksessa
FI941137A7 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI962954A7 (fi) Substituoidut 3-arylideeni-7-atsaoksindoliyhdisteet ja menetelmä niiden valmistamiseksi
FI943773A7 (fi) Uudet makrosykliset laktonit ja niitä tuottava kanta
NO973519D0 (no) Fleravtapnings- bore- og produksjonsinnretning
FI953919A7 (fi) Pyrrolydeenimetyylijohdannaiset ja menetelmä niiden valmistamiseksi
ITMI931215A0 (it) Nuovi composti fotocromatici e metodo per la loro preparazione
FI973103L (fi) Puhallettava tyyny ja menetelmä sen valmistamiseksi
FI942298A0 (fi) Menetelmä ja sovitelma tilaelementtien siirtämiseksi
FI942294A7 (fi) Bentsopyraanijohdannaiset ja niiden käyttö
DE69730605D1 (de) Dragier-produkte und herstellungsverfahren
FI931346A7 (fi) Butadieenijohdokset ja menetelmä niiden valmistamiseksi
ATE249436T1 (de) Herstellungsverfahren
FI923855A0 (fi) Katalysaattori ja sen valmistusmenetelmä
FI973434L (fi) Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi
FI956140L (fi) Menetelmä keraamien kaltaisten materiaalien valmistamiseksi ja keraamien kaltaisia materiaaleja
FI942046L (fi) Polysykliset yhdisteet ja menetelmä niiden valmistamiseksi
FI945337L (fi) Puuperäiset muotokappaleet ja menetelmä niiden valmistamiseksi
FI922437A7 (fi) Tetrasykliset antibiootit ja menetelmä niiden valmistamiseksi

Legal Events

Date Code Title Description
MA Patent expired